{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:51:18Z","timestamp":1774957878324,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00467-021-04920-4","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:06:39Z","timestamp":1611014799000},"page":"1907-1914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-5928","authenticated-orcid":false,"given":"Daishi","family":"Hirano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kakegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Takemasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawakami","family":"Yuhei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"4920_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G","year":"2000","unstructured":"Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342:145\u2013153","journal-title":"N Engl J Med"},{"key":"4920_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","volume":"362","author":"KM Fox","year":"2003","unstructured":"Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362:782\u2013788","journal-title":"Lancet"},{"key":"4920_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00467-006-0399-5","volume":"22","author":"RJ Hogg","year":"2007","unstructured":"Hogg RJ, Delucchi A, Sakihara G, Wells TG, Tenney F, Batisky DL, Blumer JL, Vogt BA, Lo MW, Hand E, Panebianco D, Rippley R, Shaw W, Shahinfar S (2007) A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension. Pediatr Nephrol 22:695\u2013701","journal-title":"Pediatr Nephrol"},{"key":"4920_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00148581-200608010-00005","volume":"8","author":"K Momma","year":"2006","unstructured":"Momma K (2006) ACE inhibitors in pediatric patients with heart failure. Paediatr Drugs 8:55\u201369","journal-title":"Paediatr Drugs"},{"key":"4920_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/00148581-200507010-00003","volume":"7","author":"RF Robinson","year":"2005","unstructured":"Robinson RF, Nahata MC, Batisky DL, Mahan JD (2005) Pharmacologic treatment of chronic pediatric hypertension. Paediatr Drugs 7:27\u201340","journal-title":"Paediatr Drugs"},{"key":"4920_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ahj.2008.01.031","volume":"155","author":"S Balamuthusamy","year":"2008","unstructured":"Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E (2008) Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis. Am Heart J 155:791\u2013805","journal-title":"Am Heart J"},{"key":"4920_CR7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","volume":"385","author":"SC Palmer","year":"2015","unstructured":"Palmer SC, Mavridis D, Navarese E, Craig JC, Tonelli M, Salanti G, Wiebe N, Ruospo M, Wheeler DC, Strippoli GFM (2015) Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis. Lancet 385:2047\u20132056","journal-title":"Lancet"},{"key":"4920_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.7326\/0003-4819-115-7-513","volume":"115","author":"RD Toto","year":"1991","unstructured":"Toto RD, Mitchell HC, Lee HC, Milam C, Pettinger WA (1991) Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. Ann Intern Med 115:513\u2013519","journal-title":"Ann Intern Med"},{"key":"4920_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archinte.160.5.685","volume":"160","author":"GL Bakris","year":"2000","unstructured":"Bakris GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160:685\u2013693","journal-title":"Arch Intern Med"},{"key":"4920_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/ki.2011.79","volume":"80","author":"FA Holtkamp","year":"2011","unstructured":"Holtkamp FA, de Zeeuw D, Thomas MC, Cooper ME, de Graeff PA, Hillege HJL, Parving HH, Brenner BM, Shahinfar S, Lambers Heerspink HJ (2011) An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int 80:282\u2013287","journal-title":"Kidney Int"},{"key":"4920_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2011.132","volume":"80","author":"MR Weir","year":"2011","unstructured":"Weir MR (2011) Acute fall in glomerular filtration rate with renin-angiotensin system inhibition: a biomeasure of therapeutic success? Kidney Int 80:235\u2013237","journal-title":"Kidney Int"},{"key":"4920_CR12","doi-asserted-by":"publisher","first-page":"j791","DOI":"10.1136\/bmj.j791","volume":"356","author":"M Schmidt","year":"2017","unstructured":"Schmidt M, Mansfield KE, Bhaskaran K, Nitsch D, S\u00f8rensen HT, Smeeth L, Tomlinson LA (2017) Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study. BMJ 356:j791","journal-title":"BMJ"},{"key":"4920_CR13","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/CJN.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832\u20131843","journal-title":"Clin J Am Soc Nephrol"},{"key":"4920_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF00852829","volume":"5","author":"DC Heilbron","year":"1991","unstructured":"Heilbron DC, Holliday MA, al-Dahwi A, Kogan BA (1991) Expressing glomerular filtration rate in children. Pediatr Nephrol 5:5\u201311","journal-title":"Pediatr Nephrol"},{"key":"4920_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00246-013-0813-2","volume":"35","author":"KA Lindle","year":"2014","unstructured":"Lindle KA, Dinh K, Moffett BS, Kyle WB, Montgomery NM, Denfield SD, Knudson JD (2014) Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease. Pediatr Cardiol 35:499\u2013506","journal-title":"Pediatr Cardiol"},{"key":"4920_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00431-015-2680-8","volume":"175","author":"C Terano","year":"2016","unstructured":"Terano C, Ishikura K, Miura M, Hamada R, Harada R, Sakai T, Hamasaki Y, Hataya H, Ando T, Honda M (2016) Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors. Eur J Pediatr 175:631\u2013637","journal-title":"Eur J Pediatr"},{"key":"4920_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"4920_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1\u2013138","journal-title":"Kidney Int Suppl"},{"key":"4920_CR19","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00467-007-0721-x","volume":"23","author":"L Patzer","year":"2008","unstructured":"Patzer L (2008) Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol 23:2159\u20132173","journal-title":"Pediatr Nephrol"},{"key":"4920_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000480358","volume":"46","author":"D Hirano","year":"2017","unstructured":"Hirano D, Ito A, Yamada A, Kakegawa D, Miwa S, Umeda C, Chiba K, Takemasa Y, Tokunaga A, Ida H (2017) Independent risk factors and 2-year outcomes of acute kidney injury after surgery for congenital heart disease. Am J Nephrol 46:204\u2013209","journal-title":"Am J Nephrol"},{"key":"4920_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1253\/circj.CJ-66-0083","volume":"78","author":"JCS Joint Working Group","year":"2014","unstructured":"JCS Joint Working Group (2014) Guidelines for drug therapy in pediatric patients with cardiovascular diseases (JCS 2012). Digest version. Circ J 78:507\u2013533","journal-title":"Circ J"},{"key":"4920_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1056\/NEJM198809083191007","volume":"319","author":"KF Badr","year":"1988","unstructured":"Badr KF, Ichikawa I (1988) Prerenal failure: a deleterious shift from renal compensation to decompensation. N Engl J Med 319:623\u2013629","journal-title":"N Engl J Med"},{"key":"4920_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/ki.1984.8","volume":"25","author":"J Schnermann","year":"1984","unstructured":"Schnermann J, Briggs JP, Weber PC (1984) Tubuloglomerular feedback, prostaglandins, and angiotensin in the autoregulation of glomerular filtration rate. Kidney Int 25:53\u201364","journal-title":"Kidney Int"},{"key":"4920_CR24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMra064398","volume":"357","author":"JG Abuelo","year":"2007","unstructured":"Abuelo JG (2007) Normotensive ischemic acute renal failure. N Engl J Med 357:797\u2013805","journal-title":"N Engl J Med"},{"key":"4920_CR25","first-page":"290","volume":"15","author":"GJ Lee","year":"2010","unstructured":"Lee GJ, Cohen R, Chang AC, Cleary JP (2010) Angiotensin converting enzyme inhibitor (ACEI)-induced acute renal failure in premature newborns with congenital heart disease. J Pediatr Pharmacol Ther 15:290\u2013296","journal-title":"J Pediatr Pharmacol Ther"},{"key":"4920_CR26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00467-003-1121-5","volume":"18","author":"S Dutta","year":"2003","unstructured":"Dutta S, Narang A (2003) Enalapril-induced acute renal failure in a newborn infant. Pediatr Nephrol 18:570\u2013572","journal-title":"Pediatr Nephrol"},{"key":"4920_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/PCC.0b013e31820ac40a","volume":"12","author":"BS Moffett","year":"2011","unstructured":"Moffett BS, Goldstein SL, Adusei M, Kuzin J, Mohan P, Mott AR (2011) Risk factors for postoperative acute kidney injury in pediatric cardiac surgery patients receiving angiotensin-converting enzyme inhibitors. Pediatr Crit Care Med 12:555\u2013559","journal-title":"Pediatr Crit Care Med"},{"key":"4920_CR28","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00246-013-0850-x","volume":"35","author":"P Ghazi","year":"2014","unstructured":"Ghazi P, Moffett BS, Cabrera AG (2014) Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients. Pediatr Cardiol 35:767\u2013770","journal-title":"Pediatr Cardiol"},{"key":"4920_CR29","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:2103\u20132116","journal-title":"N Engl J Med"},{"key":"4920_CR30","first-page":"170","volume":"42","author":"AK Mandal","year":"1994","unstructured":"Mandal AK, Markert RJ, Saklayen MG, Mankus RA, Yokokawa K (1994) Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure. Clin Nephrol 42:170\u2013174","journal-title":"Clin Nephrol"},{"key":"4920_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0002-8703(99)70009-8","volume":"138","author":"EL Knight","year":"1999","unstructured":"Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J (1999) Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD). Am Heart J 138:849\u2013855","journal-title":"Am Heart J"},{"key":"4920_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/01.pcc.0000256612.40265.67","volume":"8","author":"D Bailey","year":"2007","unstructured":"Bailey D, Phan V, Litalien C, Ducreut T, M\u00e9rouani A, Lacroix J, Gauvin F (2007) Risk factors of acute renal failure in critically ill children: a prospective descriptive epidemiological study. Pediatr Crit Care Med 8:29\u201335","journal-title":"Pediatr Crit Care Med"},{"key":"4920_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mrdd.20157","volume":"13","author":"SL Sherman","year":"2007","unstructured":"Sherman SL, Allen EG, Bean LH, Freeman SB (2007) Epidemiology of down syndrome. Ment Retard Dev Disabil Res Rev 13:221\u2013227","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"4920_CR34","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s00467-005-1825-9","volume":"20","author":"S M\u00e1laga","year":"2005","unstructured":"M\u00e1laga S, Pardo R, M\u00e1laga I, Orejas G, Fern\u00e1ndez-Toral J (2005) Renal involvement in down syndrome. Pediatr Nephrol 20:614\u2013617","journal-title":"Pediatr Nephrol"},{"key":"4920_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12291-013-0308-1","volume":"28","author":"VB Kute","year":"2013","unstructured":"Kute VB, Vanikar AV, Shah PR, Gumber MR, Patel HV, Engineer DP, Thakkar UG, Trivedi HL (2013) Down syndrome with end-stage renal disease. Indian J Clin Biochem 28:429\u2013432","journal-title":"Indian J Clin Biochem"},{"key":"4920_CR36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1152\/jappl.1967.23.4.579","volume":"23","author":"SP Coburn","year":"1967","unstructured":"Coburn SP, Seidenberg M, Mertz ET (1967) Clearance of uric acid, urea, and creatinine in Down's syndrome. J Appl Physiol 23:579\u2013580","journal-title":"J Appl Physiol"},{"key":"4920_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cca.2006.01.018","volume":"369","author":"YC Chen","year":"2006","unstructured":"Chen YC, Wang PW, Pan TL, Wallace CG, Chen CJ (2006) Proteomic analysis of Down's syndrome patients with gout. Clin Chim Acta 369:89\u201394","journal-title":"Clin Chim Acta"},{"key":"4920_CR38","doi-asserted-by":"publisher","first-page":"e615","DOI":"10.1542\/peds.2009-0181","volume":"124","author":"JC Kupferman","year":"2009","unstructured":"Kupferman JC, Druschel CM, Kupchik GS (2009) Increased prevalence of renal and urinary tract anomalies in children with down syndrome. Pediatrics 124:e615\u2013e621","journal-title":"Pediatrics"},{"key":"4920_CR39","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3109\/15513819109065484","volume":"11","author":"I Ariel","year":"1991","unstructured":"Ariel I, Wells TR, Landing BH, Singer DB (1991) The urinary system in down syndrome: a study of 124 autopsy cases. Pediatr Pathol 11:879\u2013888","journal-title":"Pediatr Pathol"},{"key":"4920_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1053\/ajkd.1998.v31.pm9469506","volume":"31","author":"A Lo","year":"1999","unstructured":"Lo A, Brown HG, Fivush BA, Neu AM, Racusen LC (1999) Renal disease in down syndrome: autopsy study with emphasis on glomerular lesions. Am J Kidney Dis 31:329\u2013335","journal-title":"Am J Kidney Dis"},{"key":"4920_CR41","first-page":"11","volume":"8","author":"A Br\u00e1s","year":"2018","unstructured":"Br\u00e1s A, Rodrigues AS, Gomes B, Rueff J (2018) Down syndrome and microRNAs. Biomed Rep 8:11\u201316","journal-title":"Biomed Rep"},{"key":"4920_CR42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbrc.2010.08.067","volume":"400","author":"L Zheng","year":"2010","unstructured":"Zheng L, Xu CC, Chen WD, Shen WL, Ruan CC, Zhu LM, Zhu DL, Gao PJ (2010) MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts. Biochem Biophys Res Commun 400:483\u2013488","journal-title":"Biochem Biophys Res Commun"},{"key":"4920_CR43","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/HYPERTENSIONAHA.118.11126","volume":"72","author":"G Wu","year":"2018","unstructured":"Wu G, Jose PA, Zeng C (2018) Noncoding RNAs in the regulatory network of hypertension. Hypertension 72:1047\u20131059","journal-title":"Hypertension"},{"key":"4920_CR44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1161\/01.HYP.28.4.569","volume":"28","author":"RA Morrison","year":"1996","unstructured":"Morrison RA, McGrath A, Davidson G, Brown JJ, Murray GD, Lever AF (1996) Low blood pressure in Down's syndrome: a link with Alzheimer's disease? Hypertension 28:569\u2013575","journal-title":"Hypertension"},{"key":"4920_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1352\/0895-8017(2002)107<0201:DICDRB>2.0.CO;2","volume":"107","author":"CC Draheim","year":"2002","unstructured":"Draheim CC, McCubbin JA, Williams DP (2002) Differences in cardiovascular disease risk between nondiabetic adults with mental retardation with and without down syndrome. Am J Ment Retard 107:201\u2013211","journal-title":"Am J Ment Retard"},{"key":"4920_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1086\/519979","volume":"81","author":"P Sethupathy","year":"2007","unstructured":"Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatziegeorgiou AG, Antonarakis SE (2007) Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81:405\u2013413","journal-title":"Am J Hum Genet"},{"key":"4920_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00246-011-0046-1","volume":"33","author":"CM Phelps","year":"2012","unstructured":"Phelps CM, Eshelman J, Cruz ED, Pan Z, Kaufman J (2012) Acute kidney injury after cardiac surgery in infants and children: evaluation of the role of angiotensin-converting enzyme inhibitors. Pediatr Cardiol 33:1\u20137","journal-title":"Pediatr Cardiol"},{"key":"4920_CR48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1471-2369-15-184","volume":"15","author":"JH Greenberg","year":"2014","unstructured":"Greenberg JH, Coca S, Parikh CR (2014) Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review. BMC Nephrol 15:184","journal-title":"BMC Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-04920-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-04920-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-04920-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T10:08:21Z","timestamp":1674900501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-04920-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4920"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-04920-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"This retrospective study involving human participants was conducted in accordance with the tenets of the Declaration of Helsinki and the Ethical Guidelines for Epidemiological Research of the Ministry of Health, Labor and Welfare of Japan. Approval was obtained from the Ethics Review Committee of Jikei University School of Medicine (ID: 9887).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The requirements for informed consent and consent for publication were waived because of the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/consent to publish"}}]}}